Company Update: Bristol-Myers Squibb Company (NYSE:BMY) – Merck, Bristol heat up immunotherapy race in lung cancer

[Reuters – UK Focus] – Bristol-Myers Squibb and Merck & Co broke further away from rival drugmakers in the race to treat lung cancer with a new generation of immune system therapies, adding . . . → Read More: Company Update: Bristol-Myers Squibb Company (NYSE:BMY) – Merck, Bristol heat up immunotherapy race in lung cancer Similar Articles: Market Update (NYSE:BMY): Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2014 on January 27 Stock Update (NYSE:BMY): Bristol immunotherapy gets 6-month U.S. FDA review for melanoma